Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Privia Health (PRVA) Invested Capital (2020 - 2026)

Privia Health has reported Invested Capital over the past 6 years, most recently at $737.2 million for Q4 2025.

  • For Q4 2025, Invested Capital rose 7.87% year-over-year to $737.2 million; the TTM value through Dec 2025 reached $737.2 million, up 7.87%, while the annual FY2025 figure was $737.2 million, 7.87% up from the prior year.
  • Invested Capital for Q4 2025 was $737.2 million at Privia Health, down from $762.8 million in the prior quarter.
  • Over five years, Invested Capital peaked at $762.8 million in Q3 2025 and troughed at $149.4 million in Q1 2021.
  • A 5-year average of $560.5 million and a median of $581.2 million in 2023 define the central range for Invested Capital.
  • Biggest five-year swings in Invested Capital: soared 229.44% in 2021 and later increased 7.87% in 2025.
  • Year by year, Invested Capital stood at $450.2 million in 2021, then increased by 15.3% to $519.0 million in 2022, then rose by 17.02% to $607.4 million in 2023, then increased by 12.52% to $683.4 million in 2024, then increased by 7.87% to $737.2 million in 2025.
  • Business Quant data shows Invested Capital for PRVA at $737.2 million in Q4 2025, $762.8 million in Q3 2025, and $733.5 million in Q2 2025.